The company is a Korea-based company mainly engaged in the manufacture and sale of prescription drugs. The Company operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The Company sells its products within domestic market and to overseas markets. The Company was established on April 1, 2014. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on August 9, 2021.
Headquarters
239, Osongsaengmyeong 2-Ro, Osong-Eup, Heungdeok-Gu
Cheongju; Chungcheongbuk;
Contact Details: Purchase the Hk Inno.N Corporation report to view the information.
Website: http://www.inno-n.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service